NOTE TO READERS: When this project lost substantial funding at the end of 2018, I lost the ability to continue publishing criteria-driven news story reviews and PR news release reviews - once the bread-and-butter of the site going back to 2006. The 3,200 archived reviews, while still educational, are getting old and difficult for me to technically maintain on the back end of the website. So I am announcing that I plan to remove these reviews from the site by April 1, 2021. The blog and the toolkit - two of the most popular features on the site - will remain. If you wish to peruse the reviews before they disappear, please do so by the end of March 2021. After that date you may still be able to access them via the Internet Archive Wayback Machine -

Cardiobrief raises questions of disease-mongering & conflicts of interest in familial hypercholesterolemia guidance

On his Cardiobrief blog, Larry Husten introduces:

“…the first of a three-part series on the National Lipid Association. This first part focuses on the NLA’s publication of a series of papers offering expert guidance on familial hypercholesterolemia (FH) and raises serious questions about the role of industry in the documents. The second part explores additional questions about the NLA’s relationships with industry and the management of the organization. In the third part the NLA answers questions sent to them about some of the issues raised in this series.”

You might also like


Please note, comments are no longer published through this website. All previously made comments are still archived and available for viewing through select posts.

Marilyn Mann

May 17, 2011 at 9:11 pm

There is no question that FH is a genuine disease, one that causes early heart disease in a high percentage of cases if untreated. I think where the disease mongering comes in is in an “awareness” campaign aimed at the general public. This just isn’t going to work if your aim is really to diagnose people with FH. FH is just not a disease the average person can self-diagnose. It takes a knowledgeable person to do it. So to the extent this campaign motivates anyone to go to their doctor to ask if they have FH, the yield will be very low. Only 1/500 people in the U.S. have heterozygous FH, so most of those people will not turn out to have it.
Some of them will get put on a statin anyway though!